Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tycho Baumann

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Leukemia & Lymphoma|November 9, 2017
The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemiaAlejandra Martínez-Trillos, Magda Pinyol, Julio Delgado, et al.
Leukemia|January 3, 2023
Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CTAna Jiménez-Ubieto, María Poza, Alejandro Martin-Muñoz, et al.
Cancers|January 8, 2025
The Value of Bone Marrow Assessment by FDG PET/CT, Biopsy and Aspirate in the Upfront Evaluation of Mantle Cell Lymphoma: A Nationwide Cohort StudyIsabel Ródenas Quiñonero, Javier Marco-Ayala, Tzu-Hua Chen-Liang, et al.
Frontiers in Immunology|June 21, 2023
Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patientsAna Jiménez-Ubieto, Alejandro Martín-Muñoz, María Poza, et al.
Nature Cancer|June 3, 2021
The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcomeMartí Duran-Ferrer, Guillem Clot, Ferran Nadeu, et al.
Frontiers in Immunology|September 4, 2023
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patientsAna Jiménez-Ubieto, Alejandro Martín-Muñoz, María Poza, et al.
Frontiers in Immunology|January 25, 2024
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patientsAna Jiménez-Ubieto, Alejandro Martín-Muñoz, María Poza, et al.
Molecular Therapy. Methods & Clinical Development|January 10, 2019
Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic InstitutionsMaria Castella, Anna Boronat, Raquel Martín-Ibáñez, et al.
Hemasphere|October 9, 2024
Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCLAlfredo Rivas-Delgado, Cristina López, Guillem Clot, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 3, 2020
CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19<sup>+</sup> Relapsed/Refractory MalignanciesValentín Ortíz-Maldonado, Susana Rives, Maria Castellà, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Leukemia & Lymphoma|November 9, 2017
The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemiaAlejandra Martínez-Trillos, Magda Pinyol, Julio Delgado, et al.
Leukemia|January 3, 2023
Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CTAna Jiménez-Ubieto, María Poza, Alejandro Martin-Muñoz, et al.
Cancers|January 8, 2025
The Value of Bone Marrow Assessment by FDG PET/CT, Biopsy and Aspirate in the Upfront Evaluation of Mantle Cell Lymphoma: A Nationwide Cohort StudyIsabel Ródenas Quiñonero, Javier Marco-Ayala, Tzu-Hua Chen-Liang, et al.
Frontiers in Immunology|June 21, 2023
Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patientsAna Jiménez-Ubieto, Alejandro Martín-Muñoz, María Poza, et al.
Nature Cancer|June 3, 2021
The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcomeMartí Duran-Ferrer, Guillem Clot, Ferran Nadeu, et al.
Frontiers in Immunology|September 4, 2023
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patientsAna Jiménez-Ubieto, Alejandro Martín-Muñoz, María Poza, et al.
Frontiers in Immunology|January 25, 2024
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patientsAna Jiménez-Ubieto, Alejandro Martín-Muñoz, María Poza, et al.
Molecular Therapy. Methods & Clinical Development|January 10, 2019
Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic InstitutionsMaria Castella, Anna Boronat, Raquel Martín-Ibáñez, et al.
Hemasphere|October 9, 2024
Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCLAlfredo Rivas-Delgado, Cristina López, Guillem Clot, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 3, 2020
CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19<sup>+</sup> Relapsed/Refractory MalignanciesValentín Ortíz-Maldonado, Susana Rives, Maria Castellà, et al.
Pageof 6